St. Louis-based Mid-America Transplant is partnering with MediGO, a logistics and communications company, on a plan to improve the transportation of organs for transplant.
The arrangement should allow transplant surgeons to better monitor the location of organs during time-sensitive transit, the pair announced.
In a release, Mid-America Transplant said it expects to achieve an important milestone in 2021 when it takes cares of its 2,500th donor at its on-site recovery facility. By completing organ donations at the facility, which the organization describes as first of its kind in the world, Mid-America Transplant has better control over the quality and efficiency of the transplant process.
Mid-America Transplant is located at 1100 Highlands Plaza Drive, 100, in St. Louis, which is just south of Forest Park.
“Time is of the essence in organ donation. We often have just hours from the time of donation until the organ needs to be transplanted, and that may include traveling hundreds of miles to reach the recipient,” said Dr. Jason Wellen, a transplant surgeon from Barnes Jewish Hospital in St. Louis. “With MediGO’s technology, all of us involved will be able to see where the organ is and its condition in real-time, so we can be fully prepared as soon as it arrives at our hospital.”
The MediGO platform uses a proprietary algorithm to predict and provide an accurate ETA. All stakeholders are informed in real time about changes to the ETA, so they can better manage resources and improve the chances of the organ being transplanted. These parties are informed of flight delays or diversions due to weather, so they can adjust as needed to give the organ the best chance of success.
“We’re excited to partner with Mid-America Transplant, who is seen as a leader in the organ procurement industry with a history of innovation,” said Dr. Joseph Scalea, co-founder and chief medical officer of MediGO. “Our vision has been to revolutionize the organ transplantation community by tracking every piece of data along an organ’s life-saving journey, which is why we’ve worked closely with OPOs to design a solution that saves time, money and improves the quality of the gift of life.”
Previously, approximately 20 percent of Mid-America Transplant’s organs traveled outside its service territory. Today, that number is closer to 70 percent, due largely to regulatory changes to how kidneys and livers are allocated nationally. As more organs travel farther, the level of control and transparency MediGO provides through the transportation process will be more critical than ever before.
“It’s our responsibility to the best possible stewards of the gifts donors and their families provide,” said Diane Brockmeier, president and CEO of MidAmerica Transplant. “Incredible innovations, like MediGO’s platform, give organs the best possible chance to get placed successfully, so their loved one’s legacy can live on in another.”
MediGO is a logistics platform that enables real time management of time-sensitive medical shipments on a centralized communication channel. It is a portfolio company within JSP Ventures.
About Mid-America Transplant
Mid-America Transplant has for more than 40 years facilitated and coordinated organ, tissue and eye donation, and now serves 84 counties covering eastern Missouri, southern Illinois and northeast Arkansas. Mid-America Transplant was the first such organization in the U.S. to use an in-house operating room for organ recovery and pioneered innovative models of increasing donor registry enrollment in an effort to provide organs and tissues to those in need. It is federally designated as one of 58 such organizations in the U.S. Visit www.midamericatransplant.org.